A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline-Reference-Cited by-同舟云学术

A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline

Published:2014-09-01 Issue:17 Volume:71 Page:1457-1461
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Yam Felix K.¹,Kwan Brian K.¹

Affiliation:

1. Felix K. Yam, Pharm.D., M.A.S., BCPS, is Assistant Clinical Professor of Pharmacy, University of California (UC) San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla. Brian K. Kwan, M.D., is Assistant Clinical Professor of Medicine, UC San Diego School of Medicine, La Jolla

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/71/17/1457/28048807/ajhp1457.pdf

Reference16 articles.

1. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens;Steed;Pharmacotherapy,2010

2. Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections;Talbot;Antimicrob Agents Chemother,2007

3. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients;Lin;J Infect Chemother,2013

4. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy;Ho;J Antimicrob Chemother,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02

2. Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe Infections;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2019-07-21

3. Methicillin‐resistantStaphylococcus aureusin solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice;Clinical Transplantation;2019-06-20

4. Comparison of Adverse Drug Reactions Between Patients Treated With Ceftaroline or Ceftriaxone: A Single-Center, Matched Cohort Study;Open Forum Infectious Diseases;2019-06-13

5. Ceftaroline-Associated Neutropenia: Case Series and Literature Review of Incidence, Risk Factors, and Outcomes;Open Forum Infectious Diseases;2019-03-28